跳至主要内容
临床试验/NCT00505817
NCT00505817已完成4 期

GnRH Agonist and Antagonists in an Oocyte Donation Program

Instituto Valenciano de Infertilidad, IVI VALENCIA2 个研究点 分布在 1 个国家开始时间: 2007年7月25日最近更新:
适应症
相关药物

试验速览

阶段
4 期
状态
已完成
发起方
试验地点
2

研究概览

简要总结

The primary purpose of this study is to evaluate the effect of the two different protocols (long protocol vs antagonist protocol) on oocyte / embryo quality.

详细描述

The cycles with antagonists of the GnRHa present a series of advantages with respect the GnRHa in an oocyte donation program: treatment cycles are simpler and shorter, a lower amount of dose of gonadotrophins is needed for stimulation, and most important, a decreased rate of ovarian hyperstimulation syndrome is observed. Nevertheless, several clinical trials relate their use to a greater rate of abortion and worse oocyte/ embryo quality. In order to discriminate the endometrial factor from the quality of oocyte cohort, the best strategy is the oocyte donation model. In the present study, for the first time, the effect of different protocols (long versus antagonist protocol) will be studied in the same donor, acting as its own control, undergoing COH. We will compare the COH´s parameters and IVF outcome obtained in the same donor submitted to, firstly, GnRH antagonist protocol (Cetrorelix- n= 45) versus another consecutive cycle with long protocol (Ac. Leuprolide- n= 45).

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Crossover
盲法
None

入排标准

年龄范围
18 Years 至 34 Years(Adult)
性别
Female
接受健康志愿者

入选标准

  • oocyte donors with age range: 18 - 34; BMI: 18 - 29 kg/m2;

排除标准

  • 未提供

研究者

发起方
Instituto Valenciano de Infertilidad, IVI VALENCIA
申办方类型
Other

研究点 (2)

Loading locations...

相似试验

GnRH Agonist and Antagonists in an Oocyte Donation... | 临床试验